Tata Memorial Hospital: a Peerless Icon

BRAF V600E Mutations and Beyond: A Molecular Perspective of Melanoma from a Tertiary Cancer Referral Center of India

“… 27 At Tata Memorial Hospital, which is the premier cancer referral center of India, the incidence of MM is 0.3% among cutaneous malignancies and even rarer among non-cutaneous malignancies. 14 …”

“…13 As per the Tata Memorial Hospital registry, MM constitutes 0.3% of the total cases reported. 14 Interestingly, some studies have shown a distinct prevalent histopathological subtype; different sites of presentation, risk factors, as well as underlying mutations, in cases of MM occurring within Asian patients. 15 Currently, there is sparse literature describing the mutation spectrum in MM among the Indian population.…”

Survivorship Care for People With Cancer in the Indo-Pacific: The Imperative to Harness Political Determinants, International Exchange, and Technological Innovation

“… 12 For example, Indonesia has recently established several bilateral partnerships between the Dharmais National Cancer Center, their national referral center, and academic and clinical institutes in India, including cancer centers such as the Tata Memorial Hospital. 13 , 14 In the low- and middle-income countries in the region, as well as the small island developing states, digital health and m-health can offer the best opportunity to increase access to quality specialist services while supporting patients and families in health literacy and decision making; these efforts must be coupled with investment in the information and communication technology infrastructure so as not to exacerbate the digital divide for small countries such as the Pacific Islands and Timor Leste. Notably, technology is rarely one-size fits-all, particularly in the diverse context of the Indo-Pacific countries.…”